enrasentan has been researched along with l 753037 in 1 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (l 753037) | Trials (l 753037) | Recent Studies (post-2010) (l 753037) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 18 | 1 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WT; Lamba, S; Suresh, DP | 1 |
1 review(s) available for enrasentan and l 753037
| Article | Year |
|---|---|
New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Topics: Bosentan; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Indans; Peptides, Cyclic; Prognosis; Pyridines; Pyrimidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome | 2000 |